N/A
N=115
Effects of Cardiac Rehabilitation (CR) on Functional Capacity and Cardiovascular Risk Factors
Cardiovascular Disease · Coronary Disease
Bottom Line
View on ClinicalTrials.gov: NCT02575976 ↗Enrolled (actual)
115
Serious AEs
0.0%
Results posted
Apr 2022
Primary outcome: Primary: Functional Capacity Assessed by Changes in Total Distance Walked in the Incremental Shuttle Walk Test — 488.1; 464.8; 394.0 meters
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- comprehensive CR (Behavioral); exercise-based CR (Other); wait list control (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Federal University of Minas Gerais
- Primary completion
- Oct 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Functional Capacity Assessed by Changes in Total Distance Walked in the Incremental Shuttle Walk Test |
488.1; 464.8; 394.0 | — |
| SECONDARY Risk Factors Measurement of Systolic Blood Pressure |
114.6; 114.4; 120.0 | — |
| SECONDARY Risk Factors Measurement of Waist Circumference. |
95.5; 93.0; 94.9 | — |
| SECONDARY Risk Factors Measurement of Fasting Blood Glucose Values |
99.8; 98.8; 94.2 | — |
| SECONDARY Risk Factors Measurement of Total Cholesterol Values. |
150.6; 169.3; 153.1 | — |
Summary
The purpose of this trial are to pragmatically investigate whether participation in a comprehensive CR (i.e., exercise with education) program in a Latin American MIC results in better functional capacity, cardiovascular risk factor control, health behavior, disease-related knowledge, depressive symptoms and lower mortality when compared exercise only CR or wait list control.
Eligibility Criteria
Inclusion Criteria
- patients older than 18 years old
- patients living in the Belo Horizonte area
Exclusion Criteria
- any comorbid physical or serious mental condition which would interfere with the ability to exercise according to CR clinical practice guidelines (i.e., heart failure with ejection fraction less than 45%, complex ventricular dysrhythmia, advanced dementia, leg amputation, advanced cancer, disabling stroke, Parkinson's or substance dependence), and
- any visual or cognitive condition which would preclude the participant from completing the questionnaires.
Data sourced from ClinicalTrials.gov (NCT02575976). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.